Clinical Trials Related to Hematology
The study and treatment of diseases that affect the production of blood and its components, such as blood cells, hemoglobin, blood proteins, bone marrow, platelets, blood vessels, spleen, and the mechanism of coagulation. Such diseases might include hemophilia, blood clots, other bleeding disorders and blood cancers such as leukemia, multiple myeloma, and lymphoma.
There are many types of lymphoma, which is a type of cancer. One type is Hodgkin disease. The rest are called non-Hodgkin lymphomas. Non-Hodgkin lymphomas begin when a type of white blood cell, called a T cell or B cell becomes abnormal. The cell divides, again and again, making more and more abnormal cells. These abnormal cells can spread to almost any other part of the body. Most of the time, doctors don’t know why a person gets non-Hodgkin lymphoma. You are at increased risk if you have a weakened immune system or have certain types of infections.
Myelofibrosis is a relatively rare bone marrow/blood cancer. It is currently classified by the World Health Organization as a myeloproliferative neoplasm, in which the proliferation of an abnormal clone of hematopoietic stem cells in the bone marrow results in the deposition in the bone marrow of collagen and reticule fiber fibrosis, as well as the remodeling of the bone component of the marrow that impairs new blood cell formation.